BAM
KITE

Barrett Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Barrett Asset Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-200
Closed -$11K – 353
2015
Q3 		$11K Buy
+200
New +$12.6K ﹤0.01% 273

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barrett Asset Management's KITE Position: Q4 2015 in Review

Barrett Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2015, closing a stake of 200 shares — an estimated $11K sold.

Barrett Asset Management first reported a position in KITE in Q3 2015 and held it in 1 quarter. The position peaked at $11K in Q3 2015. 187 funds tracked by Wall St. Rank hold KITE as of Q4 2015.

  • Barrett Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • Barrett Asset Management sold 200 Kite Pharma, Inc. shares in Q4 2015, an estimated $11K.
  • Barrett Asset Management first reported a position in Kite Pharma, Inc. in Q3 2015 and held it in 1 quarter.
  • Barrett Asset Management's Kite Pharma, Inc. position peaked at $11K in Q3 2015.
  • 187 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2015.

Based on Barrett Asset Management's 13F filing for Q4 2015, filed 5 Feb 2016.